- Home
- FTV vs WAT Comparison
FTV vs WAT Comparison
Compare FTV & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTV
- WAT
- Stock Information
- Founded
- FTV 2015
- WAT 1958
- Country
- FTV United States
- WAT United States
- Employees
- FTV N/A
- WAT N/A
- Industry
- FTV Industrial Machinery/Components
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- FTV Industrials
- WAT Industrials
- Exchange
- FTV Nasdaq
- WAT Nasdaq
- Market Cap
- FTV 26.3B
- WAT 22.5B
- IPO Year
- FTV N/A
- WAT 1995
- Fundamental
- Price
- FTV $78.90
- WAT $384.05
- Analyst Decision
- FTV Buy
- WAT Hold
- Analyst Count
- FTV 14
- WAT 13
- Target Price
- FTV $87.82
- WAT $363.92
- AVG Volume (30 Days)
- FTV 2.7M
- WAT 537.6K
- Earning Date
- FTV 01-29-2025
- WAT 02-04-2025
- Dividend Yield
- FTV 0.41%
- WAT N/A
- EPS Growth
- FTV 7.50
- WAT N/A
- EPS
- FTV 2.50
- WAT 10.48
- Revenue
- FTV $6,195,200,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- FTV $4.13
- WAT $0.53
- Revenue Next Year
- FTV $4.43
- WAT $5.59
- P/E Ratio
- FTV $31.55
- WAT $36.66
- Revenue Growth
- FTV 3.06
- WAT N/A
- 52 Week Low
- FTV $66.15
- WAT $279.24
- 52 Week High
- FTV $87.10
- WAT $395.50
- Technical
- Relative Strength Index (RSI)
- FTV 60.97
- WAT 57.31
- Support Level
- FTV $77.74
- WAT $380.14
- Resistance Level
- FTV $79.80
- WAT $395.50
- Average True Range (ATR)
- FTV 1.05
- WAT 10.42
- MACD
- FTV 0.18
- WAT 0.22
- Stochastic Oscillator
- FTV 80.16
- WAT 79.13
About FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.1 billion in revenue in 2023.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.